Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -37.01% is 25% above its 5-year average of -49.04%, near the high end of its 5-year range (-395.83%–64.68%).
78.27% above its 12-month average of -170.34%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): -193.49%.
GROSS MARGIN
-37.01%
GROSS MARGIN AVG TTM
-170.34%
GROSS MARGIN AVG 3Y
-72.76%
GROSS MARGIN AVG 5Y
-49.04%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+78.27%
CURRENT VS 3Y AVG
+49.13%
CURRENT VS 5Y AVG
+24.53%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-189.82%
vs the sector median at left
OneMedNet Corporation
Market Cap
$28.31M
Gross Margin
-37.01%
TTM Avg
-170.34%
3Y Avg
-72.76%
5Y Avg
-49.04%
Market Cap
$28.10M
Gross Margin
62.59%
TTM Avg
69.78%
3Y Avg
74.14%
5Y Avg
76.12%
Market Cap
$28.08M
Gross Margin
-423.83%
TTM Avg
-211.91%
3Y Avg
-105.96%
5Y Avg
-82.75%
Market Cap
$27.79M
Gross Margin
-717.37%
TTM Avg
-308.69%
3Y Avg
-108.42%
5Y Avg
-83.18%
Market Cap
$29.37M
Gross Margin
79.97%
TTM Avg
68.44%
3Y Avg
57.05%
5Y Avg
51.79%
Market Cap
$29.57M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$27.03M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$29.74M
Gross Margin
-3398.93%
TTM Avg
-1699.46%
3Y Avg
-849.73%
5Y Avg
-566.49%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OneMedNet Corporation (ONMD) | $28.31M | -37.01% | -170.34% | -72.76% | -49.04% |
| BeyondSpring Inc. (BYSI)vs › | $28.47M | 0.00% | 0.00% | 25.00% | 50.00% |
| iTonic Holdings Ltd. (ITOC)vs › | $28.10M | 62.59% | 69.78% | 74.14% | 76.12% |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.08M | -423.83% | -211.91% | -105.96% | -82.75% |
| aTyr Pharma, Inc. (ATYR)vs › | $27.79M | -717.37% | -308.69% | -108.42% | -83.18% |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | 79.97% | 68.44% | 57.05% | 51.79% |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $27.03M | 0.00% | 0.00% | 0.00% | 0.00% |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | -3398.93% | -1699.46% | -849.73% | -566.49% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.91M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
-37.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -193.49% |
| 2026-03-31 | -395.83% |
| 2025-12-31 | 18.52% |
| 2025-09-30 | -125.42% |
| 2025-06-30 | -155.48% |
| 2025-03-31 | -163.50% |
| 2024-12-31 | -100.00% |
| 2024-09-30 | -59.15% |
| 2024-06-30 | -44.93% |
| 2024-03-31 | -27.82% |
| 2023-12-31 | 0.99% |
| 2023-09-30 | 10.12% |
| 2023-06-30 | -32.95% |
| 2023-03-31 | -44.50% |
| 2022-12-31 | 64.68% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -31.79% |
| 2022-03-31 | -12.60% |
| 2021-12-31 | 7.98% |
| 2021-09-30 | -42.33% |
